Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • ...

    Tag: non small cell lung cancer

    You Searched For "non-small-cell-lung-cancer"
    Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer

    Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer

    Medical Dialogues Bureau28 March 2020 11:45 AM IST
    TEPMETKO is the first regulatory approval globally for an oral MET inhibitor indicated for the treatment of advanced NSCLC harboring MET gene...
    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Pfizer gets EU nod to VIZIMPRO for treating lung cancer

    Farhat Nasim6 April 2019 9:40 AM IST
    New Delhi: Pfizer Inc. recently announced that the European Commission has approved VIZIMPRO (dacomitinib), a tyrosine kinase inhibitor (TKI), as...
    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Shilpa Medicare gets USFDA nod for Gemcitabine to treat types of cancer

    Farhat Nasim27 Feb 2019 9:30 AM IST
    The company has received US Food and Drug Administration (USFDA) approval for its Abbreviated New Drug Application (ANDA), Gemcitabine for injection...
    FDA approves Pfizer

    FDA approves Pfizer's Lorbrena treatment for certain lung cancer patients

    Medical Dialogues Bureau7 Nov 2018 9:40 AM IST
    Lorbrena, known chemically as lorlatinib, received an accelerated approval, Pfizer said. Its continued approval may depend on verification of clinical...
    Biocon launches colon cancer drug in India, priced Rs 24,000

    Biocon launches colon cancer drug in India, priced Rs 24,000

    Ruby Khatun Khatun24 Nov 2017 10:01 AM IST
    Bengaluru: Biocon Ltd has launched KRABEVA, a biosimilar Bevacizumab for the treatment of patients with metastatic colorectal cancer and other types...
    CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer

    CDSCO grants approval to AstraZeneca India for Breakthrough Therapy of lung cancer

    Ruby Khatun Khatun13 Nov 2017 5:39 PM IST
    Through a recent notification, Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Ministry of Health and...
    Roche cancer immunotherapy Tecentriq wins EU approval

    Roche cancer immunotherapy Tecentriq wins EU approval

    Ruby Khatun Khatun25 Sept 2017 10:17 AM IST
    ZURICH: Roche immunotherapy Tecentriq has won European Union approval for treating advanced lung and bladder cancer, the Swiss drugmaker said.The...
    AstraZeneca rebuilds cancer drug hopes with new lung data

    AstraZeneca rebuilds cancer drug hopes with new lung data

    Ruby Khatun Khatun12 Sept 2017 9:32 AM IST
    MADRID: Two AstraZeneca drugs tackling lung cancer in different ways delivered encouraging results on Saturday, helping the British group offset...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok